INSP
Inspire Medical Systems, Inc. NYSE Listed May 3, 2018$45.57
After hrs
$44.26
+0.00%
Mkt Cap $1.3B
52w Low $44.41
1.0% of range
52w High $161.88
50d MA $56.24
200d MA $82.09
P/E (TTM)
11.4x
EV/EBITDA
40.6x
P/B
2.1x
Debt/Equity
0.0x
ROE
18.6%
P/FCF
34.5x
RSI (14)
—
ATR (14)
—
Beta
0.86
50d MA
$56.24
200d MA
$82.09
Avg Volume
1.2M
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
5500 Wayzata Boulevard · Golden Valley, MN 55416 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.28 | 0.10 | +136.3% | 54.84 | -14.3% | -12.0% | -16.7% | -16.9% | — | — | — |
| Feb 11, 2026 | AMC | 0.69 | 1.65 | +139.1% | 67.94 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% | — |
| Nov 3, 2025 | AMC | -0.15 | 0.38 | +353.3% | 73.71 | +8.5% | +15.3% | +12.4% | +13.7% | +11.0% | +16.8% | — |
| Aug 4, 2025 | AMC | 0.22 | 0.45 | +104.5% | 129.95 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% | — |
| May 5, 2025 | AMC | -0.23 | 0.10 | +143.5% | 158.74 | -8.9% | +2.0% | -1.4% | -3.7% | -4.7% | -1.4% | — |
| Feb 10, 2025 | AMC | 0.74 | 1.15 | +55.4% | 180.99 | -5.8% | +1.7% | +3.3% | +3.4% | +2.6% | -0.5% | — |
| Nov 4, 2024 | AMC | 0.08 | 0.60 | +650.0% | 192.71 | +3.2% | +3.3% | +9.8% | +4.0% | +2.0% | +4.8% | — |
| Aug 6, 2024 | AMC | -0.14 | 0.32 | +328.6% | 147.01 | +17.0% | +28.1% | +27.7% | +31.4% | +32.8% | +30.7% | — |
| May 7, 2024 | AMC | -0.63 | -0.34 | +46.0% | 245.63 | -27.1% | -33.5% | -29.0% | -31.7% | -35.0% | -35.4% | — |
| Feb 6, 2024 | AMC | -0.09 | 0.49 | +644.4% | 226.00 | -0.4% | -10.5% | -10.6% | -13.8% | -13.1% | -16.7% | — |
| Nov 7, 2023 | AMC | -0.53 | -0.29 | +45.3% | 161.74 | -14.1% | -19.7% | -21.5% | -22.3% | -22.6% | -17.7% | — |
| Aug 1, 2023 | AMC | -0.51 | -0.41 | +19.6% | 290.93 | +0.2% | -4.5% | -2.3% | -4.7% | -8.7% | -15.8% | — |
| May 2, 2023 | AMC | -0.70 | -0.53 | +24.3% | 257.30 | +4.9% | +7.0% | +3.8% | +7.7% | +9.7% | +12.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5 | BofA Securities | Downgrade | Buy → Neutral | $53 | $54.84 | $47.00 | -14.3% | -12.0% | -16.7% | -16.9% | — | — |
| May 5 | Piper Sandler | Downgrade | Overweight → Neutral | $55 | $54.84 | $47.00 | -14.3% | -12.0% | -16.7% | -16.9% | — | — |
| Apr 15 | Truist | Maintains | Hold → Hold | — | $56.83 | $56.83 | +0.0% | -0.3% | -0.7% | +1.3% | +0.2% | -8.4% |
| Apr 13 | Mizuho | Maintains | Outperform → Outperform | — | $54.02 | $53.77 | -0.5% | +1.7% | +5.2% | +4.9% | +4.5% | +6.6% |
| Apr 10 | Stifel | Maintains | Buy → Buy | — | $56.69 | $56.00 | -1.2% | -4.7% | -3.1% | +0.2% | -0.1% | -0.4% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $54.99 | $56.41 | +2.6% | -1.5% | -1.0% | -2.9% | +3.1% | -1.8% |
| Mar 5 | Stifel | Maintains | Buy → Buy | — | $64.32 | $62.49 | -2.8% | -2.9% | -2.1% | -3.8% | -7.6% | -6.8% |
| Feb 13 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $59.65 | $59.64 | -0.0% | +0.2% | +1.2% | +3.8% | +0.2% | -0.2% |
| Feb 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Feb 12 | Jefferies | Maintains | Hold → Hold | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Feb 12 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Feb 12 | Truist | Maintains | Hold → Hold | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Feb 12 | Mizuho | Maintains | Outperform → Outperform | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Feb 12 | Baird | Downgrade | Outperform → Neutral | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Feb 12 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $67.94 | $55.52 | -18.3% | -12.2% | -12.0% | -11.1% | -8.9% | -12.0% |
| Jan 27 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $81.33 | $79.20 | -2.6% | +0.6% | +0.8% | -3.4% | -6.8% | -9.7% |
| Jan 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $92.46 | $92.10 | -0.4% | +0.6% | +4.3% | -0.2% | +2.2% | +4.0% |
| Jan 8 | Truist | Maintains | Buy → Buy | — | $99.03 | $97.99 | -1.1% | -4.1% | -0.7% | -2.1% | -6.6% | -6.0% |
| Dec 23 | UBS | Maintains | Neutral → Neutral | — | $97.93 | $95.98 | -2.0% | -3.0% | -2.3% | -2.5% | -4.3% | -5.5% |
| Dec 17 | Mizuho | Maintains | Outperform → Outperform | — | $115.51 | $117.95 | +2.1% | +2.4% | -17.5% | -16.4% | -15.2% | -17.8% |
| Dec 17 | RBC Capital | Maintains | Outperform → Outperform | — | $115.51 | $117.95 | +2.1% | +2.4% | -17.5% | -16.4% | -15.2% | -17.8% |
| Dec 16 | JP Morgan | Maintains | Neutral → Neutral | — | $119.26 | $120.91 | +1.4% | -3.1% | -0.8% | -20.1% | -19.1% | -17.9% |
| Dec 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $136.81 | $140.69 | +2.8% | +5.2% | +2.7% | +2.4% | +0.4% | -4.5% |
| Dec 8 | Oppenheimer | Upgrade | Perform → Outperform | — | $136.81 | $140.69 | +2.8% | +5.2% | +2.7% | +2.4% | +0.4% | -4.5% |
| Dec 4 | Baird | Maintains | Outperform → Outperform | — | $134.75 | $138.07 | +2.5% | +3.9% | +1.5% | +6.9% | +4.3% | +3.9% |
| Dec 2 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $126.34 | $125.08 | -1.0% | +6.0% | +6.7% | +10.8% | +8.3% | +14.0% |
| Nov 26 | Truist | Upgrade | Hold → Buy | — | $130.39 | $130.61 | +0.2% | -2.3% | -4.6% | -3.1% | +2.7% | +3.3% |
| Nov 25 | Wolfe Research | Upgrade | Peer Perform → Outperform | — | $117.29 | $120.48 | +2.7% | +11.2% | +8.6% | +6.1% | +7.7% | +14.2% |
| Nov 24 | Stifel | Upgrade | Hold → Buy | — | $89.87 | $105.74 | +17.7% | +30.5% | +45.1% | +41.7% | +38.4% | +40.6% |
| Nov 4 | Truist | Maintains | Hold → Hold | — | $73.71 | $80.01 | +8.5% | +15.3% | +12.4% | +13.7% | +11.0% | +16.8% |
| Nov 4 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $73.71 | $80.01 | +8.5% | +15.3% | +12.4% | +13.7% | +11.0% | +16.8% |
| Nov 4 | JP Morgan | Maintains | Neutral → Neutral | — | $73.71 | $80.01 | +8.5% | +15.3% | +12.4% | +13.7% | +11.0% | +16.8% |
| Nov 4 | RBC Capital | Maintains | Outperform → Outperform | — | $73.71 | $80.01 | +8.5% | +15.3% | +12.4% | +13.7% | +11.0% | +16.8% |
| Nov 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $73.71 | $80.01 | +8.5% | +15.3% | +12.4% | +13.7% | +11.0% | +16.8% |
| Oct 24 | Jefferies | Downgrade | Buy → Hold | — | $80.17 | $79.00 | -1.5% | -3.3% | -2.5% | -3.7% | -6.2% | -8.9% |
| Oct 15 | Truist | Maintains | Hold → Hold | — | $78.84 | $78.72 | -0.2% | +0.0% | -1.9% | -1.1% | +2.5% | +5.0% |
| Oct 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $76.37 | $76.51 | +0.2% | +0.6% | +2.8% | +4.9% | -1.6% | +1.7% |
| Sep 22 | UBS | Downgrade | Buy → Neutral | — | $79.88 | $77.67 | -2.8% | -1.7% | -3.6% | -2.6% | -3.2% | -3.3% |
| Aug 15 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $84.58 | $84.88 | +0.4% | +3.8% | +4.4% | +6.5% | +10.0% | +8.3% |
| Aug 5 | Stifel | Maintains | Hold → Hold | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | Lake Street | Maintains | Buy → Buy | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | JP Morgan | Downgrade | Overweight → Neutral | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | UBS | Maintains | Buy → Buy | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | RBC Capital | Maintains | Outperform → Outperform | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | Truist | Downgrade | Buy → Hold | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Aug 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $129.95 | $88.75 | -31.7% | -32.4% | -39.6% | -40.7% | -39.1% | -38.7% |
| Jul 22 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $125.14 | $124.45 | -0.6% | +3.4% | +5.1% | +2.8% | +3.0% | +4.5% |
No insider trades available.
Data updated apr 25, 2026 3:47pm
· Source: massive.com